Results 31 to 40 of about 7,059,453 (271)
Lifeline of New Products- Destination: The Patient\u27s Bedside [PDF]
The lifeline of a new product begins with an innovative process driven by an on-line request through our academic medical center’s intranet system. The individual championing the new product completes the request.
Mangano, MSN, RN New Products Coordinator, Department of Nursing Education, Mary Bent
core +1 more source
A new way to iterate Brzezi\'nski crossed products
If $A\otimes _{R, \sigma }V$ and $A\otimes _{P, \nu }W$ are two Brzezi\'nski crossed products and $Q:W\otimes V\rightarrow V\otimes W$ is a linear map satisfying certain properties, we construct a Brzezi\'{n}ski crossed product $A\otimes _{S, \theta }(V ...
Dăuş, Leonard, Panaite, Florin
core +1 more source
ABSTRACT Background Oral mucositis is a common and debilitating side effect of childhood cancer and stem cell transplant treatments. It affects the quality of life of children and young people (CYP) and places a strain on services. Photobiomodulation is recommended for oral mucositis prevention in international guidance but is poorly implemented in UK ...
Claudia Heggie +4 more
wiley +1 more source
Purpose: determination of the opportunities and definition of prospects of diversification in the field of production of new products (in the case of the nuclear industry), which allows to match the level of a new technological stage and to achieve state
D. Yu. Faikov, D. Yu. Baydarov
doaj +1 more source
Buyer beware? : does the information provided with herbal products available over the counter enable safe use? [PDF]
Background: Herbal products obtained over the counter are commonly used in Europe, North America and Australia. Although there is concern about a lack of information provided to consumers to allow the safe use of these products, there has been no ...
Dickinson, Rebecca +4 more
core +2 more sources
Clinical Insights Into Hypercalcemia of Malignancy in Childhood
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley +1 more source
Offshore petroleum and minerals: Plugging gaps in the present framework [PDF]
For twenty years, it has been realized that there is a gap in New Zealand’s environmental law in that there is no general environmental legislation for the exclusive economic zone, and now for the extended continental shelf that includes areas more than ...
Barton, Barry
core +2 more sources
Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul +13 more
wiley +1 more source
ABSTRACT Background Kaposiform lymphangiomatosis (KLA) is an aggressive complex lymphatic anomaly. Patients exhibit malformed lymphatic vessels and often develop hemorrhagic effusions and elevated angiopoietin‐2 (Ang‐2) levels. A somatic NRAS p.Q61R (NRASQ61R) mutation has been associated with KLA.
C. Griffin McDaniel +3 more
wiley +1 more source
ABSTRACT In pediatric patients, T‐cell lymphoblastic lymphoma (T‐LBL) survival exceeds 80%. Relapse remains associated with limited curative options. Frontline treatment is largely extrapolated from T‐cell acute lymphoblastic leukemia (T‐ALL) treatment, reflecting the ongoing debate, whether both entities represent distinct diseases or variants within ...
Marie C. Heider +4 more
wiley +1 more source

